Why ICL planning is a visit sequence, not a single appointment
Implantable collamer lens (ICL) surgery places a lens inside the eye while keeping the natural lens. The FDA notes that deciding on phakic lens surgery requires a medical and eye history and examination, including eye measurements such as anterior chamber depth and endothelial cell count. Those measurements cannot be replaced by a phone call or a records review.
For an international patient, this means the practical unit of planning is a set of visits, not one appointment. A typical route discussed with the hospital may include an assessment visit, a treatment visit and at least one review visit. The exact number, spacing and content are set by the treating ophthalmologist and the hospital, not by a travel agency or an article.
ChinaSpecialistCare can coordinate appointment timing and hospital navigation, but it does not decide whether ICL is suitable. That decision belongs to the licensed ophthalmology team after examination.
- Assessment visit: history, examination and eye measurements
- Treatment visit: only if the hospital confirms suitability and the patient agrees
- Review visit or visits: to check the eye and discuss aftercare
Records and questions to prepare before the assessment
The FDA's checklist for phakic lens surgery suggests patients should discuss past eye conditions and eye surgery, current medicines, allergies, risks, benefits, alternatives and follow-up. Those topics are useful preparation for any ICL assessment, in China or elsewhere.
Bring what you already have rather than trying to complete a full archive before first contact. Existing prescriptions, previous eye examination reports, glasses or contact lens prescriptions, and records of any earlier eye operation help the ophthalmologist understand your history. Ask the ophthalmologist which existing measurements can be used and which need updating before surgery.
Write your questions down. Useful ones include: which measurements will be taken at assessment; what the hospital needs from me before the treatment visit; whether both eyes are planned in one session or separately; what aftercare and review schedule is expected; and who to contact if something changes after I return home. Ask the hospital directly rather than assuming a standard answer.
- Current glasses or contact lens prescription
- Previous eye examination or imaging reports you already hold
- Records of any earlier eye surgery or eye condition
- A list of current medicines and allergies
- Your written questions about risks, alternatives and follow-up
What the hospital must confirm, and what remote review cannot do
A records-based opinion can help you understand whether travelling for assessment is worth considering, but it cannot establish final eligibility. The FDA source is clear that the decision depends on examination and measurements, including anterior chamber depth and endothelial cell count. Ask where those measurements must be obtained and whether existing results are acceptable.
The hospital also decides whether ICL is available for your case, which lens is selected, and how the treatment and review visits are scheduled. Do not treat a remote review, an initial enquiry or a coordination quote as hospital acceptance. If your vision is worsening, painful or suddenly changed, seek local urgent eye care before planning travel.
Availability and approval of a device in one country do not automatically mean the same product or route is available in China. Ask the hospital what it currently offers for your situation.
- Final suitability: hospital ophthalmologist after examination
- Lens selection and treatment plan: treating clinical team
- Visit dates and review schedule: hospital, subject to confirmation
- Remote review: useful preparation, not final eligibility
Practical arrangements around the treatment and review visits
Once the hospital confirms a plan, arrange travel so that you are not rushing between the assessment and treatment visits. Ask whether the hospital expects a gap between assessment and treatment, and whether any pre-treatment instructions apply. Follow the hospital's instructions rather than a generic timeline.
Language and reporting arrangements vary by hospital. Ask whether interpretation is available for the consultation, whether reports are issued in English, and how results will be shared with you. ChinaSpecialistCare can provide bilingual hospital navigation and interpretation as a separately agreed coordination service, but it does not provide clinical care or guarantee a particular hospital's language service.
Keep provider charges, coordination fees and travel costs separate in your planning. Hospital consultation, tests, treatment and medicines are paid to the hospital or relevant provider. ChinaSpecialistCare coordination fees are separate. Ask for a records-based estimate from the hospital rather than relying on a general figure.
- Confirm the expected gap between assessment and treatment
- Ask how results and aftercare instructions will be given to you
- Plan accommodation near the hospital for the visit sequence
- Keep hospital fees, coordination fees and travel costs separate
How to start planning without overcommitting
You do not need to buy a proxy consultation to begin. A free initial case review can look at the diagnosis or eye records you have, your main question and what information is missing, then suggest a relevant next step. This is not a diagnosis and not a promise of acceptance.
If you decide to proceed, specialist matching and appointment coordination can help with timing and visit preparation, and hospital, treatment and surgery coordination can support admission and treatment arrangements after hospital acceptance. The hospital still decides suitability and the final plan.
- Start with a short summary of your eye history and main question
- Share records only after first contact and only what is requested
- Ask the hospital to confirm the visit sequence in writing
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.